Table 3.58.
Key considerations in dental management in G6PD deficiency (see text)
Management modifications* | Comments/possible complications | |
---|---|---|
Risk assessment | 1 | Avoid oxidant drugs |
Appropriate dental care | 2 | Avoid oxidant drugs |
Pain and anxiety control | ||
– Local anaesthesia | 1 | Avoid prilocaine |
– Conscious sedation | 1 | |
– General anaesthesia | 3/4 | |
Patient access and positioning | ||
– Access to dental office | 0 | |
– Timing of treatment | 0 | |
– Patient positioning | 0 | |
Treatment modification | ||
– Oral surgery | 0 | |
– Implantology | 0 | |
– Conservative/Endodontics | 0 | |
– Fixed prosthetics | 0 | |
– Removable prosthetics | 0 | |
– Non-surgical periodontology | 0 | |
– Surgical periodontology | 0 | |
Hazardous and contraindicated drugs | 2 | Avoid aspirin, acetaminophen, sulphonamides and topical toluidine blue |
0 = No special considerations. 1 = Caution advised. 2 = Specialised medical advice recommended in some cases. 3 = Specialised medical advice mandatory. 4 = Only to be performed in hospital environment. 5 = Should be avoided.